If the cancer tests negative for over-expression of the her2 / neu oncogene , weekly chemotherapy with taxol or taxotere is an effective option with acceptable side effects .
This dramatically reduces the risk of relapse in breast-cancer patients whose tumours make a protein called her2 / neu , and only those women whose tumours produce this protein will respond to the drug .
